Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

The PRIMA study

Prof Gilles Salles - Universite Claude Bernard Lyon, France
The PRIMA study ( Prof Gilles Salles - Universite Claude Bernard Lyon, France )
20 Jul 2010

ALK mutation related non-small cell lung cancer

Prof George Demetri - Harvard Medical School, USA
ALK mutation related non-small cell lung cancer ( Prof George Demetri - Harvard Medical School, USA )
20 Jul 2010

A new centre of excellence for lung cancer treatment

Dr Thierry Le Chevalier - Gustave-Roussy Institute, Villejuif, France
A new centre of excellence for lung cancer treatment ( Dr Thierry Le Chevalier - Gustave-Roussy Institute, Villejuif, France )
30 Jun 2010

Clinical trial Design: Comparator arms

Prof David Cameron, Dr Christopher M Nutting, Dr Ruth Pettengell, Professor Jacek Jassem
Clinical trial Design: Comparator arms ( Prof David Cameron, Dr Christopher M Nutting, Dr Ruth Pettengell, Professor Jacek Jassem )
30 Jun 2010

Primary end points of clinical trials - overall survival versus progression free survival.

Prof David Cameron, Prof Patrick Schöffski, Prof Hilary Calvert
Primary end points of clinical trials - overall survival versus progression free survival. ( Prof David Cameron, Prof Patrick Schöffski, Prof Hilary Calvert )
30 Jun 2010

Current techniques in the treatment of lung cancer

Prof Jacek Jassem - University of Gdansk, Poland
Current techniques in the treatment of lung cancer ( Prof Jacek Jassem - University of Gdansk, Poland )
29 Jun 2010

Roundup of the 2010 ASCO conference

Prof Gordon McVie - European Institute of Oncology, Milan
Roundup of the 2010 ASCO conference ( Prof Gordon McVie - European Institute of Oncology, Milan )
11 Jun 2010

ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration

Prof Yung-Jue Bang - Seoul National University College of Medicine, Seoul, Korea
ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration ( Prof Yung-Jue Bang - Seoul National University College of Medicine, Seoul, Korea )
11 Jun 2010

New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer

Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St. James's Institute of Oncology, Leeds, UK
New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer ( Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St. James's Institute of Oncology, Leeds, UK )
11 Jun 2010

Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma

Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica, California
Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma ( Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica, California )
11 Jun 2010

The role of genetic mutations in lung cancer

Prof Fred Hirsch - University of Colorado, Denver
The role of genetic mutations in lung cancer ( Prof Fred Hirsch - University of Colorado, Denver )
8 Jun 2010

The use of targeted radiotherapy to treat lung cancer

Prof Paul Van Houtte - Institut Jules Bordet, Brussels
The use of targeted radiotherapy to treat lung cancer ( Prof Paul Van Houtte - Institut Jules Bordet, Brussels )
7 Jun 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation